Por: ABC News Business August 22, 2023
WASHINGTON -- The generic drug maker Teva Pharmaceuticals agreed Monday to pay $225 million to settle price-fixing charges related to sales of a major cholesterol-lowering drug. The U.S. Department of Justice said the agreement also requires Teva to divest its business making and selling the drug, pravastatin, a generic version of the brand-name medicine Pravachol. Another generic drug maker, Glenmark Pharmaceuticals, agreed to pay a $30 million... + full article
Politico USA Health August 22, 2023
Two generic drug giants agreed Monday to settle long-running criminal price-fixing charges with the Justice Department, including the unusual move to sell off the drugs involved. The U.S. arms of and are paying $225 million and $30 million, respectively, according to court... + más
Antitrust Has a Generic-Drug Problem | The Atlantic
How one U.S. drugmaker contributed to the escalating drug shortage crisis | NBC News
WPLG Local 10 USA Health August 22, 2023
WASHINGTON – The generic drug maker Teva Pharmaceuticals agreed Monday to pay $225 million to related to sales of a major cholesterol-lowering drug. The U.S. Department of Justice said the agreement also requires Teva to divest its business making and selling the drug,... + más
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis | ABC News
How To Lower Your Cholesterol Naturally, According To Heart Experts | Forbes
ABC News USA Health August 22, 2023
WASHINGTON -- The generic drug maker Teva Pharmaceuticals agreed Monday to pay $225 million to settle price-fixing charges related to sales of a major cholesterol-lowering drug. The U.S. Department of Justice said the agreement also requires Teva to divest its business making... + más
MarketWatch USA Business May 18, 2023
Teva’s ADR jumped 7.3% on Thursday morning, as investors awaited an investor day presentation scheduled to start at 12 p.m. Eastern. The drugmaker has been struggling since a series of ill-advised acquisitions a decade ago, notably the decision to buy Actavis Generics for... + más
What Are the Duties of A Trustee? | Forbes
Forbes USA Life March 01, 2023
Photo Credit: Gettygetty Nearly 94 million Americans over the age of 20—which is approximately 40% of the U.S. population—have high cholesterol, reports the (CDC). Having high blood cholesterol increases the risk for heart disease, which is as well as for stroke—, notes... + más
What to Know if Your Doctor Put You on Statins to Lower Cholesterol | Time
HDL or ‘good’ cholesterol might not make a difference to heart health: study | New York Post
Time USA Health January 25, 2023
High cholesterol is a prime example of having too much of a good thing. Our bodies naturally make this substance in the liver and then transport it throughout the body for multiple functions, including hormone regulation, cell tissue regeneration, and vitamin absorption. When... + más
Do Statins Increase the Risk of Diabetes? | The New York Times
How to Control High Cholesterol, According to Patients | Time
ABC News USA Health November 03, 2022
Teva Pharmaceuticals agreed Thursday to pay $523 million to settle claims stemming from the company’s role in the It’s the largest settlement New York has reached with an individual opioid defendant and raises the total amount secured from opioid manufacturers and... + más
New York Attorney General Letitia James secures $523 million from Teva Pharmaceuticals for role in opioid crisis | CNN
Teva Pharmaceuticals Will Pay Up To $523 Million In New York For Opioid Settlement | Forbes
About iurex | Privacy Policy | Disclaimer |